GRN and frontotemporal dementia: Genetic variants in TMEM106B associated with reduced TMEM106B expression have been shown to significantly protect individuals with either GRN mutations or C9ORF72 repeat expansions from the development of FTD symptoms [13, 19, 21, 30, 37, 58–60].